RT Journal Article
SR Electronic
A1 Canavan, Neil
T1 Vaginal Brachytherapy for High-Intermediate Risk Endometrial Cancers
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 4
SP 12
OP 12
DO 10.1177/155989770800800407
UL http://mdc.sagepub.com/content/8/4/12.1.abstract
AB Data from a randomized phase 3 trial indicate that vaginal brachytherapy (VBT) may be a better option than pelvic radiotherapy for treating high-intermediate risk (age>60 and stage 1C grade 1–2 or stage 1B grade 3; any age and stage 2A grade 1–2 or grade 3 with <50% invasion) endometrial cancers because of a lower rate of side effects, leading to enhanced quality of life. This article reports the results of the PORTEC-2 trial [NCT00376844].